(Q37738636)

22 August 2017

1 reference

title

Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis (English)

1 reference

primary sclerosing cholangitis

22 August 2017

main subject

ascending cholangitis

0 references

1 reference

primary biliary cholangitis

inferred from title

0 references

author name string

Claudia O Zein

series ordinal

1

1 reference

22 August 2017

Keith D Lindor

series ordinal

2

1 reference

22 August 2017

publication date

1 February 2010

1 reference

Current gastroenterology reports

22 August 2017

published in

1 reference

22 August 2017

volume

12

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

13-22

1 reference

Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-009-0079-2

Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-009-0079-2

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective

21 January 2018

1 reference

12 December 2020

Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease

1 reference

12 December 2020

Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis

1 reference

12 December 2020

Fenofibrate for patients with asymptomatic primary biliary cirrhosis

1 reference

12 December 2020

Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis

1 reference

12 December 2020

Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis

1 reference

12 December 2020

Tacrolimus for the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients

1 reference

12 December 2020

Sertraline as a first-line treatment for cholestatic pruritus

1 reference

12 December 2020

The immunobiology of primary sclerosing cholangitis

1 reference

12 December 2020

Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis

1 reference

12 December 2020

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial

1 reference

12 December 2020

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

12 December 2020

When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?

1 reference

12 December 2020

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group

1 reference

12 December 2020

Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience

1 reference

12 December 2020

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

1 reference

12 December 2020

Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence

1 reference

12 December 2020

Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study

1 reference

12 December 2020

Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?

1 reference

12 December 2020

Fat-soluble vitamin levels in patients with primary biliary cirrhosis

1 reference

12 December 2020

Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis.

1 reference

12 December 2020

The epidemiology of primary biliary cirrhosis

1 reference

12 December 2020

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

1 reference

12 December 2020

The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus

1 reference

12 December 2020

Autoantibodies in primary sclerosing cholangitis

1 reference

12 December 2020

Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis

1 reference

12 December 2020

The natural history of small-duct primary sclerosing cholangitis

1 reference

12 December 2020

Primary biliary cirrhosis

1 reference

12 December 2020

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 reference

12 December 2020

Primary biliary cirrhosis

1 reference

12 December 2020

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

1 reference

12 December 2020

Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis

1 reference

12 December 2020

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial

1 reference

12 December 2020

Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels.

1 reference

12 December 2020

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid

1 reference

12 December 2020

Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis

1 reference

12 December 2020

Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Small-duct primary sclerosing cholangitis

1 reference

12 December 2020

A pilot study of etanercept in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.

1 reference

12 December 2020

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

12 December 2020

Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

1 reference

12 December 2020

Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome

1 reference

12 December 2020

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

1 reference

12 December 2020

Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis

1 reference

12 December 2020

Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study

1 reference

12 December 2020

Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis

1 reference

12 December 2020

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

1 reference

12 December 2020

Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis

1 reference

12 December 2020

Increased prevalence of primary sclerosing cholangitis among first-degree relatives

1 reference

12 December 2020

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma

1 reference

12 December 2020

Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes.

1 reference

12 December 2020

Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid

1 reference

12 December 2020

An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis

1 reference

12 December 2020

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid

1 reference

12 December 2020

Primary sclerosing cholangitis: summary of a workshop

1 reference

12 December 2020

Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years

1 reference

12 December 2020

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

1 reference

12 December 2020

Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial

1 reference

12 December 2020

Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials

1 reference

12 December 2020

Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis

1 reference

12 December 2020

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

12 December 2020

Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid

1 reference

12 December 2020

Management of hepatocellular carcinoma

1 reference

12 December 2020

Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.

1 reference

12 December 2020

10.1007/S11894-009-0079-2

Identifiers

DOI

1 reference

22 August 2017

1 reference